More HOPE for Prevention with Statins
- PMID: 27039666
- DOI: 10.1056/NEJMe1603504
More HOPE for Prevention with Statins
Comment in
-
Blood-Pressure and Cholesterol Lowering in the HOPE-3 Trial.N Engl J Med. 2016 Sep 22;375(12):1192-3. doi: 10.1056/NEJMc1608916. N Engl J Med. 2016. PMID: 27653576 No abstract available.
-
Blood-Pressure and Cholesterol Lowering in the HOPE-3 Trial.N Engl J Med. 2016 Sep 22;375(12):1194. doi: 10.1056/NEJMc1608916. N Engl J Med. 2016. PMID: 28102987 No abstract available.
Comment on
-
Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease.N Engl J Med. 2016 May 26;374(21):2032-43. doi: 10.1056/NEJMoa1600177. Epub 2016 Apr 2. N Engl J Med. 2016. PMID: 27039945 Clinical Trial.
-
Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease.N Engl J Med. 2016 May 26;374(21):2021-31. doi: 10.1056/NEJMoa1600176. Epub 2016 Apr 2. N Engl J Med. 2016. PMID: 27040132 Clinical Trial.
-
Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease.N Engl J Med. 2016 May 26;374(21):2009-20. doi: 10.1056/NEJMoa1600175. Epub 2016 Apr 2. N Engl J Med. 2016. PMID: 27041480 Clinical Trial.
Similar articles
-
Is Statin Monotherapy the Perfect Polypill?Circulation. 2016 Jul 12;134(2):91-3. doi: 10.1161/CIRCULATIONAHA.116.023166. Circulation. 2016. PMID: 27400893 No abstract available.
-
The cost implication of primary prevention in the HOPE 3 trial.Eur Heart J Qual Care Clin Outcomes. 2019 Jul 1;5(3):266-271. doi: 10.1093/ehjqcco/qcz001. Eur Heart J Qual Care Clin Outcomes. 2019. PMID: 30657891 Clinical Trial.
-
Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease.N Engl J Med. 2016 May 26;374(21):2032-43. doi: 10.1056/NEJMoa1600177. Epub 2016 Apr 2. N Engl J Med. 2016. PMID: 27039945 Clinical Trial.
-
In brief: Ezallor Sprinkle--a new formulation of rosuvastatin.Med Lett Drugs Ther. 2019 Sep 23;61(1581):152. Med Lett Drugs Ther. 2019. PMID: 31599869 Review. No abstract available.
-
Telmisartan or valsartan alone or in combination with hydrochlorothiazide: a review.Clin Exp Hypertens. 2013;35(1):50-60. doi: 10.3109/10641963.2012.690468. Epub 2012 Aug 6. Clin Exp Hypertens. 2013. PMID: 22866964 Review.
Cited by
-
Does the Naked Emperor Parable Apply to Current Perceptions of the Contribution of Renin Angiotensin System Inhibition in Hypertension?Curr Hypertens Rep. 2022 Dec;24(12):709-721. doi: 10.1007/s11906-022-01229-x. Epub 2022 Oct 22. Curr Hypertens Rep. 2022. PMID: 36272015 Review.
-
Should a Statin be Given to All Hypertensive Patients?Curr Hypertens Rep. 2022 Jan;24(1):21-27. doi: 10.1007/s11906-022-01167-8. Epub 2022 Jan 24. Curr Hypertens Rep. 2022. PMID: 35072922 Review.
-
Impact of Intensive Versus Standard Blood Pressure Management by Tertiles of Blood Pressure in SPRINT (Systolic Blood Pressure Intervention Trial).Hypertension. 2018 Jun;71(6):1064-1074. doi: 10.1161/HYPERTENSIONAHA.117.10646. Epub 2018 Apr 30. Hypertension. 2018. PMID: 29712745 Free PMC article. Clinical Trial.
-
Polypills for the secondary prevention of cardiovascular disease: effective in improving adherence but are they safe?Ther Adv Drug Saf. 2018 Feb;9(2):157-162. doi: 10.1177/2042098617747836. Epub 2017 Dec 20. Ther Adv Drug Saf. 2018. PMID: 29387338 Free PMC article. Review.
-
Personalized Management of Cardiovascular Disorders.Med Princ Pract. 2017;26(5):399-414. doi: 10.1159/000481403. Epub 2017 Sep 11. Med Princ Pract. 2017. PMID: 28898880 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical